RADICAL CYSTECTOMY FOR PRIMARY BLADDER MALIGNANCY: A 10 YEAR REVIEW
- 1 April 2007
- journal article
- Published by Wiley in Anz Journal of Surgery
- Vol. 77 (4) , 265-269
Abstract
Radical cystectomy is universally accepted as the definitive treatment for muscle invasive bladder cancer and preventing stage progression in high-risk groups. There are few recent reviews outside of major international centres. We compared our institution's results with published literature. Records of 50 consecutive patients treated with radical cystectomy for biopsy-proven bladder carcinoma between 1995 and 2005 were reviewed. The mean age was 70 years and 76% were male. Median follow up was 38 months (1-111 months). Twenty-three patients (46%) had known history of superficial transitional cell carcinoma and 12 patients (24%) had undergone previously intravesical therapy. Transitional cell carcinomas accounted for 94% of cases and most (76%) were poorly differentiated. Twenty-four (48%) had disease at pT3 stage or higher. Regional lymph nodes were involved in 35%. Twenty-three patients (46%) developed recurrence and over half (12 patients) recurred within 12 months. Both lymph node involvement and recurrence were associated with higher pT stage (P < 0.001). All patients with recurrent disease were dead within a year (median 103 days). Median hospital stay was 19 days and there was one postoperative death (2%). Five-year disease-free and overall survival were 42 and 34% respectively. Survival following curative resection for primary bladder malignancy is at best modest. Our overall proportion of higher stage disease contributed to earlier recurrence and lower survival rates. Our postoperative morbidity and mortality rates as well as length of stay are acceptable compared with major international units.Keywords
This publication has 20 references indexed in Scilit:
- Defining the minimum hospital case‐load to achieve optimum outcomes in radical cystectomyBJU International, 2005
- Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic StudiesEuropean Urology, 2004
- Long-Term Outcome of Ileal Conduit Diversion.Journal of Urology, 2003
- TUMOR PROGRESSION AND SURVIVAL OF PATIENTS WITH HIGH GRADE, NONINVASIVE PAPILLARY (TaG3) BLADDER TUMORS:Journal of Urology, 2000
- THE ILEAL NEOBLADDERJournal of Urology, 1999
- Radical Cystectomy for Carcinoma of the BladderJournal of Urology, 1997
- A Randomized Trial of Radical Cystectomy Versus Radical Cystectomy Plus Cisplatin, Vinblastine and Methotrexate Chemotherapy for Muscle Invasive Bladder CancerJournal of Urology, 1996
- Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapyCancer, 1994
- THE MANAGEMENT OF INVASIVE BLADDER CANCER: A REVIEW OF SELECTED AUSTRALASIAN STUDIES IN RADIOTHERAPY, CHEMOTHERAPY AND CYSTECTOMYAnz Journal of Surgery, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958